Industry Size (2025) USD 6556.5 Mn Forecast (2035) USD 62543.2 Mn CAGR (2025 to 2035) 25.3% GLP-1 Diabetes Treatment Drugs Market Forecast and Outlook (2025-2035) The GLP-1 diabetes treatment drugs market is expected to reach USD 6,556.5 million in 2025 and expand dramatically to USD 62,543.2 million by 2035, reflecting a compound annual growth rate (CAGR) of 25.3%
Advertising for GLP-1s, therefore, should be carefully regulated and revised as needed, prior to airing across national media and social platforms
It is proven beneficial in the treatment of mild-to-moderate erectile dysfunction With proper dosing PT-141 acts within 30 minutes and effects may be felt up to 12 hours from the time of administration and have been known to last for up to 3 days, diminishing each day
3 A 2025 systematic review found no link between these drugs and higher suicidality, with some data suggesting a lower risk
Those are the things that tell me the medicine is doing a good job and helping them, said Dr